ChargePoint Technology expands US presence

Powder containment and aseptic transfer valve specialist, ChargePoint Technology, is expanding its presence in the US following a multimillion pound investment from LDC, part of Lloyds Banking Group, at the beginning of the year.

The expansion has been fuelled by the strength in the demand for its solutions, including the AseptiSafe and PharmaSafe product ranges, which are used to ensure the safe transfer of active pharmaceutical ingredients (APIs) in small and large scale pharmaceutical manufacturing environments.

Joining the team as president of ChargePoint Inc., at the San Francisco office, will be Chris Rombach, who was previously employed with ILC Dover, Pacific Ozone and Stedim Biotech. Rombach will be responsible for driving growth of the company’s product offering across the Americas, including the establishment of local sales operations and the creation of new roles in the US, as well as new reseller channels. Additionally, the company has plans to double its global workforce by 2020.

“Growing our North American presence is a significant milestone for us and reflects our strategic vision to expand the company in key markets. Our product range and AfterCare support mean we are ideally placed to meet the increasing demand for safe containment and sterile transfer solutions. The use of split-valve technology is growing in popularity, and can offer an alternative to more cumbersome and costly containment techniques,” stated Chris Eccles, CEO of ChargePoint. “Continuing our investment in our business and enhancing the service we can provide our customers at a local level has been our main priority in 2017 so far, and bringing on board new team members with the strategic vision to grow the company globally is key to our goals. We are very pleased to have Chris on board as part of our North America team and have no doubt his industry expertise is a perfect fit for the ChargePoint business.”

“To be joining ChargePoint at a time when it is experiencing significant growth and investment is very exciting. Having the opportunity to support the sale of such revolutionary products, that are receiving demand across the globe, is something I’m looking forward to being part of,” added Rombach.